Cargando…

Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development

BACKGROUND: mRNA vaccines have been investigated in multiple tumors, but limited studies have been conducted on their use for hepatocellular carcinoma (HCC). AIM: To identify candidate mRNA vaccine antigens for HCC and suitable subpopulations for mRNA vaccination. METHODS: Gene expression profiles a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Tai-Liang, Li, Cheng-Long, Gong, Yong-Qiang, Hou, Fu-Tao, Chen, Chao-Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631436/ https://www.ncbi.nlm.nih.gov/pubmed/37969406 http://dx.doi.org/10.4251/wjgo.v15.i10.1717

Ejemplares similares

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
por: Huang, Xing, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
por: Lin, Han, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development
por: Chen, Zhuohui, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
por: Ye, Liguo, et al.
Publicado: (2021)

Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells
por: Chen, Ruo-Chan, et al.
Publicado: (2017)

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
por: Huang, Xing, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development
por: Li, Ruo Qi, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development
por: Wang, Shuhang, et al.
Publicado: (2022)

mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles
por: Azhar, Nur Asna, et al.
Publicado: (2023)

Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine
por: Ping, Haiqin, et al.
Publicado: (2022)

Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development
por: Liao, Weiran, et al.
Publicado: (2022)

Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer
por: Yin, Teng-Fei, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2022)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development
por: Wang, Fan
Publicado: (2023)

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung Cancer
por: Wei, Yuanfeng, et al.
Publicado: (2023)

Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development
por: Lu, Tong, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development
por: Zhao, Jiaying, et al.
Publicado: (2022)

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
por: Wu, Changwu, et al.
Publicado: (2022)

Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer
por: Fang, Ze-Xuan, et al.
Publicado: (2023)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
por: Chen, Yan, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development
por: Wu, Yanxuan, et al.
Publicado: (2023)

Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
por: Huang, En-Min, et al.
Publicado: (2022)

Parallel mRNA, proteomics and miRNA expression analysis in cell line models of the intestine
por: O’Sullivan, Finbarr, et al.
Publicado: (2017)

Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901
por: Xie, Xiao-Que, et al.
Publicado: (2017)

Pilot study of a novel serum mRNA gene panel for diagnosis of acute septic arthritis
por: Schultz, Blake J, et al.
Publicado: (2019)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
por: Deng, Zhe, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
por: Ye, Liguo, et al.
Publicado: (2021)

Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers
por: Herring, Elizabeth, et al.
Publicado: (2017)

SmartFlare(TM) is a reliable method for assessing mRNA expression in single neural stem cells
por: Diana, Andrea, et al.
Publicado: (2021)

Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
por: Zhang, Yi-Bing, et al.
Publicado: (2023)

Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
por: Xu, Hang, et al.
Publicado: (2021)

Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development
por: Fu, Jiantao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5550rdl5ieqr2hp7la5djaqv95